Selenium, Zinc, and Hashimoto's: What the Evidence Actually Shows

Among the many supplements marketed for Hashimoto's thyroiditis, selenium and zinc have the strongest evidence base. Both are essential cofactors for thyroid hormone synthesis and conversion, and both are commonly deficient in Hashimoto's patients. This article reviews the clinical evidence, optimal dosing, safety considerations, and how these nutrients interact with the autonomic symptoms common in this population.

Selenium

Why It Matters for Hashimoto's

Selenium is a trace mineral that serves as a cofactor for three critical enzyme families in thyroid physiology:

• Deiodinases (DIO1, DIO2, DIO3): Convert T4 to active T3 (or inactive reverse T3). Without adequate selenium, conversion efficiency drops, leading to low T3 symptoms despite normal TSH.
• Glutathione peroxidases (GPx): Protect thyroid cells from oxidative damage caused by hydrogen peroxide, a byproduct of thyroid hormone synthesis. In Hashimoto's, elevated TPO antibodies generate excess oxidative stress; selenium reduces this damage.
• Thioredoxin reductases: Regulate cellular redox balance and immune function.

Clinical Evidence

The evidence for selenium in Hashimoto's is among the strongest for any supplement in autoimmune thyroid disease:

The 2017 meta-analysis is particularly important: it confirmed that selenium supplementation consistently reduces TPO antibody levels, though whether this translates to long-term disease modification remains under study.

Dosing and Safety

The standard dose studied in clinical trials is 200 mcg/day of selenomethionine (the organic form, better absorbed than selenite). This is safe for most adults. The tolerable upper intake level (UL) is 400 mcg/day; chronic intake above this level causes selenosis (hair loss, nail brittleness, neurological symptoms).

Important: patients in selenium-replete regions (most of North America and Europe) may not be deficient, and supplementation in replete individuals shows smaller benefits. Consider testing serum selenium before supplementing if possible.

Zinc

Why It Matters for Hashimoto's

Zinc is required for:

• Thyroid hormone receptor binding: Zinc finger proteins are structural components of thyroid hormone receptors; zinc deficiency impairs T3 receptor function even when T3 levels are adequate.
• Deiodinase activity: Zinc is a cofactor for DIO1, supporting T4-to-T3 conversion.
• Immune regulation: Zinc is essential for regulatory T cell (Treg) function. Tregs suppress autoimmune responses; zinc deficiency impairs Treg activity and may worsen autoimmune thyroid disease.
• Gut barrier integrity: Zinc is critical for tight junction maintenance in the intestinal epithelium. Deficiency increases intestinal permeability ("leaky gut"), which is associated with autoimmune disease progression.

Clinical Evidence

The evidence for zinc in Hashimoto's is less robust than for selenium but is growing:

• A 2015 study found that zinc supplementation (30 mg/day) in hypothyroid patients improved free T3 levels and reduced TSH compared to placebo.
• A 2019 study in Hashimoto's patients found that zinc supplementation reduced TPO antibodies and improved thyroid ultrasound findings over 12 months.
• Zinc deficiency is significantly more prevalent in Hashimoto's patients than in healthy controls in multiple studies.

Dosing and Safety

The typical therapeutic dose is 15–30 mg/day of zinc bisglycinate or zinc picolinate (chelated forms with better absorption than zinc oxide or sulfate). The UL is 40 mg/day; chronic excess causes copper deficiency (zinc and copper compete for absorption). If supplementing zinc long-term at higher doses, consider adding 1–2 mg/day of copper.

The Autonomic Connection

Both selenium and zinc have relevance for the autonomic symptoms common in Hashimoto's patients:

Selenium and dysautonomia: Selenium deficiency impairs T3 production, which directly affects heart rate, cardiac output, and autonomic tone. Selenium supplementation that improves T3 levels may reduce POTS-like symptoms in Hashimoto's patients.

Zinc and mast cells: Zinc stabilizes mast cells and reduces histamine release. In patients with concurrent MCAS, zinc supplementation may reduce mast cell reactivity and improve symptoms including flushing, hives, and GI distress.

Practical Recommendations

Test serum selenium and zinc before supplementing if possible. Both can be measured on standard lab panels. Retest after 3–6 months to confirm adequacy.

Key Takeaways

Selenium (200 mcg/day selenomethionine) has the strongest evidence base of any supplement for Hashimoto's, with multiple randomized trials showing significant reductions in TPO antibodies. Zinc (15–30 mg/day) supports T3 receptor function, conversion, and immune regulation. Both are safe at recommended doses and address mechanisms directly relevant to Hashimoto's pathophysiology and autonomic symptoms.

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any new supplement.